CodeMap® 
150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2024
2023

Physician Fee Schedule

2024
2023

OPPS Fee Schedule

2024-October
2024-July

ASC Fee Schedule

2024-October
2024-July

APC Codes

2024-October
2024-July

DRG Codes

2024
2023

ASP Drug Pricing Files

2024-October
2024-July


CMS Transmittals




CodeMap® LCD-L33394

 

Printer Friendly Version

L33394
LCD for Drugs and Biologicals, Coverage of, for Label and Off-Label Uses (L33394)
See related Articles:
A52370-Billing and Coding: Bevacizumab and biosimilars
A52371-Billing and Coding: Bortezomib
A52399-Billing and Coding: Denosumab (Prolia ™, Xgeva ™)
A52420-Billing and Coding: Hyaluronans Intra-articular Injections of
A52421-Billing and Coding: Ibandronate Sodium
A52423-Billing and Coding: Infliximab and biosimilars
A52448-Billing and Coding: Omalizumab
A52450-Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
A52451-Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll and Faricimab-svoa
A52453-Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
A52855-Billing and Coding: Drugs and Biologicals
A54548-Billing and Coding: Eculizumab
A59216-Response to Comments: Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
A59756-Response to Comments: Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

Contractor Information

Contractor Name: National Government Services, Inc. - Full list of policies of this Medicare Contractor

Contractor Number: 14512

Contractor Type: MAC B

LCD Information

LCD ID Number: L33394 Status: A-Approved

LCD Title: Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

Geographic Jurisdiction: Vermont Other Jurisdictions

Original Determination Effective Date: 10/01/2015

Original Determination Ending Date:

Revision Effective Date: 08/01/2024

Revision End Date:

CMS National Coverage Policy:

Language quoted from Centers for Medicare and Medicaid Services (CMS), National Coverage Determinations (NCDs) and coverage provisions in interpretive manuals is italicized throughout the policy. NCDs and coverage provisions in interpretive manuals are not subject to the LCD Review Process (42 CFR 405.860[b] and 42 CFR 426 [Subpart D]). In addition, an administrative law judge may not review an NCD. See Section 1869(f)(1)(A)(i) of the Social Security Act.

Unless otherwise specified, italicized text represents quotation from one or more of the following CMS sources:

Title XVIII of the Social Security Act (SSA):

Section 1862(a)(1)(A) excludes expenses incurred for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

Section 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.

CMS Publications

CMS Publication Pub 100-02, Medicare Benefit Policy Manual, Chapter 15:

    50 - Drugs and Biologicals
    50.4.5 - Off-Label Use of Drugs and Biologicals in an Anti-Cancer Chemotherapeutic Regimen

CMS Publication 100-04, Medicare Claims Processing Manual, Chapter 17:

    10 - Payment Rules for Drugs and Biologicals


Sorry, you need to login or register to view additional sections of this Medicare policy.

--
*


All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

10/05/2024 08:06:24 3.237.15.145

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.